• Chief Operating Officer

    John Michailidis

    John is an executive with more than 30 years’ of commercial pharmaceutical experience. His career has ranged from global franchise and regional executive leadership roles with F. Hoffman - La Roche to CEO experience with growth-stage biopharmaceutical companies. John holds a BSc in Genetics from LaTrobe University and executive business qualifications from Harvard Business School and INSEAD.
  • Chief Development Officer

    Simon Erskine

    Simon has more than ten years’ experience working within the biotechnology industry, IVD medical devices and molecular diagnostics. He has held positions of increasing responsibility within research and development, clinical development, regulatory and quality and product development. He has successfully translated early-stage research into commercial products for the Australian, European, Canadian and US markets, including commercialisation of novel research for the detection of antibiotic resistance markers.
    Simon has directed global teams and partnerships at scientific, strategic and operational levels, contributing to the rapid growth of Australian biotech start-ups, with roles as Principal Scientist and Director of Product Development. Simon has a history of accomplishments in directing scientific resources and teams on test development, laboratory procedures, quality and resource optimisation. Additionally, Simon has acted as Chief Principal Investigator for human research and clinical studies and participated in clinical research projects within Australia, Europe and the US.